eli lilly glp 1 drug to seek approval of new GLP-1 weight-loss this year FDA approves new weight-loss pill,

Telomere length: lights and shadows on their role in human reproduction

Khoo KS, Ooi CW, Chew KW, Foo SC, Lim JW, Tao Y, Show PL (2021) Permeabilization of Haematococcus pluvialis and solid-liquid extraction of astaxanthin by CO2-based alkyl carbamate ionic liquids

LY3437943 (Retatrutide): discovery to clinical proof of concept (triple GLP-1/GIP/glucagon agonist, preclinical mechanism) Nature Reviews Endocrinology (2024) Multi-receptor agonists for metabolic disease (mechanism of GLP-1/GIP/glucagon co-activation) Diabetes Care (2024) Incretin-based therapies: GLP-1, GIP, and glucagon receptor pharmacology (metabolic pathways, energy expenditure) NEJM (2023) Supplementary Material Jastreboff et al

These initial changes typically manifest as improved skin hydration, a slight brightening effect, and enhanced skin texture